1. Dysfunction of epithelial permeability barrier induced by HMGB1 in 2.5D cultures of human epithelial cells. Issue 2 (3rd April 2022) Authors: Kojima, Takashi; Shindo, Yuma; Konno, Takumi; Kodera, Yuki; Arai, Wataru; Miyakawa, Maki; Ohwada, Kizuku; Tanaka, Hiroki; Tsujiwaki, Mitsuhiro; Sakuma, Yuji; Kikuchi, Shin; Ohkuni, Tsuyoshi; Takano, Kenichi; Watanabe, Atsushi; Kohno, Takayuki Journal: Tissue barriers Issue: Volume 10:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HMGB1 enhances epithelial permeability via p63/TGF-β signaling in lung and terminal bronchial epithelial cells. Issue 4 (1st October 2020) Authors: Kodera, Yuki; Kohno, Takayuki; Konno, Takumi; Arai, Wataru; Tsujiwaki, Mitsuhiro; Shindo, Yuma; Chiba, Hirofumi; Miyakawa, Maki; Tanaka, Hiroki; Sakuma, Yuji; Watanabe, Atsushi; Takahashi, Hiroki; Kojima, Takashi Journal: Tissue barriers Issue: Volume 8:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term Operation Rates and Related Prognostic Factors in Patients with Crohn's Disease Treated by Infliximab: A Japanese Single‐center Cohort Study: 654. (October 2016) Authors: Nasuno, Masanao; Miyakawa, Maki; Tanaka, Hiroki; Motoya, Satoshi Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term Outcomes and Related Prognostic Factors of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease: A Single‐center Cohort Study: 702. (October 2016) Authors: Tanaka, Hiroki; Miyakawa, Maki; Nasuno, Masanao; Motoya, Satoshi Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-059 Short-Term Outcomes of Adalimumab for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. (March 2016) Authors: Miyakawa, Maki; Tanaka, Hiroki; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-059 Short-Term Outcomes of Adalimumab for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. (March 2016) Authors: Miyakawa, Maki; Tanaka, Hiroki; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-060 Mid- to Long-Term Outcomes of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. (March 2016) Authors: Tanaka, Hiroki; Miyakawa, Maki; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-060 Mid- to Long-Term Outcomes of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease and Associated Prognostic Factors. (March 2016) Authors: Tanaka, Hiroki; Miyakawa, Maki; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-073 Long-Term Outcomes of Switching from Infliximab to Adalimumab for Japanese Patients with Crohn's Disease Whose Infliximab Treatment Failed. (February 2017) Authors: Tanaka, Hiroki; Sugiyama, Kohei; Miyakawa, Maki; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-089 Short- and Long-Term Outcomes and Associated Prognostic Factors of Tacrolimus Treatment for Refractory Ulcerative Colitis: A Japanese Single-Center Study. (February 2017) Authors: Miyakawa, Maki; Tanaka, Hiroki; Sugiyama, Kohei; Sakemi, Ryosuke; Nasuno, Masanao; Motoya, Satoshi Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗